Company Performance Metrics
- John Lillig: Executive ChairmanPast Role: Nexus Biosystems, Founder and CEO
- Terry Kinninger: CFOPast Role: Estech, CFO & COO

Agena Bioscience is a molecular diagnostics company that develops and markets genetic reagents and analysis systems. Agena Bioscience's MassARRAY® System is a highly sensitive, cost-effective, mass spectrometry-based platform for high-throughput genetic analysis and is used in a range of clinical diagnostic and research fields such as
infectious diseases, cancer profiling for solid tumors and liquid biopsies, inherited genetic disease testing, pharmacogenetics, agricultural genomics, and clinical research.
The company's genetic platform delivers timely, accurate, and easy-to-interpret results, to improve decision-making and laboratory economics.